OCULAR THERAPEUTIX, INC of BEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-02-08. The offering totals $14.0M, of which $14.0M was reported sold. Industry: Biotechnology.
Showing 25 of 32 people.
| Name | Role | Location |
|---|---|---|
| Alan Crain | Director | Waltham, MA |
| Bernard Haffey | Director | Waltham, MA |
| Daniel Myers | Director | Newark, NJ |
| Alan Crain | Executive Officer | Waltham, MA |
| Bernard Haffey | Executive Officer | Waltham, MA |
| Daniel Myers | Executive Officer | Newark, NJ |
| Farhad Khosravi | Director | BEDFORD, MA |
| Farhad Khosravi | Executive Officer | BEDFORD, MA |
| Amarpreet Sawhney | Director | BEDFORD, MA |
| Amarpreet Sawhney | Executive Officer | BEDFORD, MA |
| Steven Cagnetta | Executive Officer | BEDFORD, MA |
| Samuel Wu | Director | Walpole, MA |
| Michael Goldstein | Executive Officer | Purchase, NY |
| James Garvey | Director | Chicago, IL |
| James Garvey | Executive Officer | Chicago, IL |
| Richard Lindstrom | Director | Avon by the Sea, NJ |
| Brian Levy | Director | Syosset, NY |
| Alan Crane | Director | Watertown, MA |
| Alan Crane | Executive Officer | Watertown, MA |
| Jaswinder Chadha | Director | Berkeley Heights, NJ |
| Richard L Lindstrom | Director | Nashville, TN |
| Charles Warden | Director | Pittsburgh, PA |
| Charles Warden | Executive Officer | Pittsburgh, PA |
| W. James O'Shea | Director | Waltham, MA |
| Kevin Hanley | Executive Officer | Bedford, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-03-18 | D | $37.5M | $37.5M |
| 2013-06-10 | D | $8.5M | $8.5M |
| 2011-01-12 | D/A | $21.0M | $21.0M |
| 2009-07-02 | D | $15.0M | $15.0M |
| 2009-07-01 | D | $6.0M | $6.0M |
| 2009-07-01 | D/A | $1.1M | $1.1M |